QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)

Healthcare Stocks List

Compare healthcare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Learn more about trading healthcare stocks.

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$68.83
+4.7%
$64.11
$37.55
$76.97
$5.47B1.731.88 million shs1.97 million shs
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$112.43
-0.8%
$110.32
$89.67
$115.83
$195.19B0.755.45 million shs6.98 million shs
CVS Health Co. stock logo
CVS
CVS Health
$75.09
-1.3%
$75.72
$64.41
$90.62
$96.63B0.514.19 million shs12.12 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$156.43
-1.0%
$158.20
$144.95
$175.97
$376.56B0.537.09 million shs9.75 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$735.56
+1.4%
$614.01
$309.20
$742.00
$698.27B0.323.47 million shs4.64 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$126.61
-0.7%
$113.66
$99.14
$128.06
$320.83B0.388.18 million shs6.31 million shs
Novartis AG stock logo
NVS
Novartis
$101.36
-2.0%
$102.65
$79.98
$108.78
$214.84B0.561.42 million shs1.63 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$27.56
$28.28
$25.76
$44.33
$155.59B0.6246.07 million shs29.01 million shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$20.38
+1.8%
$20.50
$15.02
$32.00
$3.37B13.56 million shs2.13 million shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$520.01
+0.1%
$526.60
$445.68
$554.70
$480.97B0.544.40 million shs3.34 million shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
-1.73%+4.40%+4.83%+28.21%+18.06%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.61%+0.13%+0.80%+21.07%+1.18%
CVS Health Co. stock logo
CVS
CVS Health
+3.10%+2.25%-5.74%+13.98%-11.56%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.06%-0.58%-2.19%+7.20%-3.32%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
+2.82%+12.37%+15.82%+22.59%+113.41%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
+0.47%+5.54%+8.60%+24.49%+20.62%
Novartis AG stock logo
NVS
Novartis
-0.25%-0.02%-3.36%+10.98%+19.84%
Pfizer Inc. stock logo
PFE
Pfizer
+0.18%+1.85%-6.84%-7.11%-36.77%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-0.37%+3.01%-9.23%+27.66%-37.01%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
+1.70%+1.49%-3.19%-3.67%+8.91%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
0.5804 of 5 stars
2.21.00.00.02.52.50.0
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9774 of 5 stars
2.35.04.24.53.82.52.5
CVS Health Co. stock logo
CVS
CVS Health
4.4 of 5 stars
2.42.03.33.93.71.71.3
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.913 of 5 stars
3.23.04.23.93.71.71.9
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4.7211 of 5 stars
2.44.02.54.03.02.51.9
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
4.5118 of 5 stars
2.43.03.34.22.62.51.3
Novartis AG stock logo
NVS
Novartis
1.7478 of 5 stars
1.23.02.50.03.10.02.5
Pfizer Inc. stock logo
PFE
Pfizer
4.9992 of 5 stars
4.23.04.24.82.43.33.1
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
1.4265 of 5 stars
3.21.00.00.01.82.50.6
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
4.9903 of 5 stars
3.44.04.24.04.02.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2.44
Hold$68.39-0.64% Downside
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.69
Moderate Buy$120.006.73% Upside
CVS Health Co. stock logo
CVS
CVS Health
2.87
Moderate Buy$92.8923.72% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.38
Hold$176.1412.61% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.79
Moderate Buy$621.81-15.46% Downside
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.76
Moderate Buy$129.682.43% Upside
Novartis AG stock logo
NVS
Novartis
2.33
Hold$99.50-1.84% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.33
Hold$36.9334.03% Upside
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.43
Hold$26.6030.55% Upside
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
2.87
Moderate Buy$575.7910.73% Upside

Current Analyst Ratings

Latest Healthcare Stocks Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/8/2024
CVS Health Co. stock logo
CVS
CVS Health
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$87.00
2/8/2024
CVS Health Co. stock logo
CVS
CVS Health
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$86.00 ➝ $84.00
2/8/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$605.00
2/7/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$650.00 ➝ $850.00
2/7/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$680.00 ➝ $810.00
2/7/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$763.00 ➝ $805.00
2/7/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$710.00 ➝ $865.00
2/6/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
2/6/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$700.00 ➝ $825.00
2/5/2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$135.00
2/2/2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$122.00 ➝ $139.00
(Data available from 2/8/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$1.20M4,555.97N/AN/A$23.95 per share2.87
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.87$5.55 per share20.26$21.17 per share5.31
CVS Health Co. stock logo
CVS
CVS Health
$322.47B0.30$12.19 per share6.16$54.28 per share1.38
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.42$12.87 per share12.15$29.39 per share5.32
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$34.12B20.46$9.56 per share76.92$11.34 per share64.86
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$60.12B5.34$9.02 per share14.04$18.17 per share6.97
Novartis AG stock logo
NVS
Novartis
$45.44B4.73$10.47 per share9.68$22.06 per share4.59
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.66$2.71 per share10.18$17.09 per share1.61
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.41B1.40$84.90 per share0.24$14.25 per share1.43
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$371.62B1.29$30.32 per share17.15$102.08 per share5.09

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
-$650.17M-$4.47N/AN/AN/A-240.84%-19.10%-15.84%2/20/2024 (Estimated)
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2634.4921.962.7414.27%20.84%10.68%4/17/2024 (Estimated)
CVS Health Co. stock logo
CVS
CVS Health
$4.15B$6.6311.338.841.662.47%15.36%4.60%5/1/2024 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$13.8111.3314.222.6537.79%36.75%14.50%4/16/2024 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.24B$5.80126.8241.352.2415.36%50.78%10.33%4/25/2024 (Estimated)
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$365M$0.14904.3613.221.640.61%9.07%3.61%4/25/2024 (Estimated)
Novartis AG stock logo
NVS
Novartis
$14.85B$7.1814.1212.471.5929.83%29.90%12.97%4/23/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B$0.3676.549.951.223.62%10.61%5.01%5/7/2024 (Estimated)
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$13.66B-$24.66N/AN/AN/A-155.12%-9.60%-5.10%2/20/2024 (Confirmed)
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$22.38B$23.8421.8116.611.396.02%26.39%8.42%4/12/2024 (Estimated)

Latest Healthcare Stocks Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/20/2024N/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.22N/A+$0.22N/AN/AN/A  
2/7/202412/31/2023
CVS Health Co. stock logo
CVS
CVS Health
$2.01$2.12+$0.11$2.66$90.58 billion$93.81 billion      
2/6/202412/31/2023
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$2.30$2.49+$0.19$2.56$8.95 billion$9.35 billion    
2/1/2024Q4 2023
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
-$0.09$0.03+$0.12$0.54$14.49 billion$14.63 billion    
1/30/202412/31/2023
Novartis AG stock logo
NVS
Novartis
$1.64$1.53-$0.11-$1.08$11.69 billion$11.42 billion    
1/30/202412/31/2023
Pfizer Inc. stock logo
PFE
Pfizer
-$0.19$0.10+$0.29$0.80$14.37 billion$14.25 billion    
1/24/202412/31/2023
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.19$1.19N/A$1.47$10.19 billion$10.24 billion    
1/23/202412/31/2023
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.28$2.29+$0.01$2.91$21.02 billion$21.40 billion    
1/12/2024Q4 2023
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$5.98$6.16+$0.18$6.49$92.13 billion$94.43 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
N/AN/AN/AN/AN/A
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.201.96%+12.31%67.48%52 Years
CVS Health Co. stock logo
CVS
CVS Health
$2.663.54%+6.56%40.12%2 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.04%+5.70%34.47%62 Years
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$4.520.61%+15.15%77.93%10 Years
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.082.43%+6.08%2,200.00%13 Years
Novartis AG stock logo
NVS
Novartis
$2.272.24%+4.26%31.62%4 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.10%+12.89%466.67%14 Years
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$7.521.45%+14.71%31.54%14 Years

Latest Healthcare Stocks Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/23/2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
quarterly$0.772.6%3/14/20243/15/20244/5/2024
12/8/2023
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.300.89%2/14/20242/15/20243/8/2024
1/2/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.193.03%2/16/20242/20/20243/5/2024
12/14/2023
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.426.43%1/25/20241/26/20243/1/2024
12/15/2023
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.552.06%1/11/20241/12/20242/15/2024
12/5/2023
CVS Health Co. stock logo
CVS
CVS Health
quarterly$0.66503.6%1/19/20241/22/20242/1/2024
11/28/2023
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
quarterly$0.773%12/14/202312/15/20231/8/2024
11/8/2023
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Quarterly$1.881.4%12/1/202312/4/202312/12/2023
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
N/A
15.83
15.83
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.38
1.74
1.23
CVS Health Co. stock logo
CVS
CVS Health
0.80
0.86
0.64
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.37
1.21
0.96
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.59
1.05
0.82
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.82
1.38
1.12
Novartis AG stock logo
NVS
Novartis
0.39
1.15
0.93
Pfizer Inc. stock logo
PFE
Pfizer
0.63
2.38
2.05
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.67
3.44
3.36
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.62
0.79
0.80

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
47379.43 million76.18 millionOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.74 billion1.72 billionOptionable
CVS Health Co. stock logo
CVS
CVS Health
300,0001.29 billion1.28 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
155,8002.41 billion2.40 billionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
39,000949.31 million948.07 millionOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
69,0002.53 billion2.53 billionOptionable
Novartis AG stock logo
NVS
Novartis
101,7032.12 billion2.12 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
83,0005.65 billion5.64 billionOptionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,600165.56 million162.86 millionOptionable
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
400,000924.92 million921.69 millionOptionable

Healthcare Stocks Headlines

SourceHeadline
Whats Going On With Health Insurance Firm UnitedHealth Stock Today?What's Going On With Health Insurance Firm UnitedHealth Stock Today?
msn.com - February 8 at 1:53 PM
UnitedHealth COO Dirk McMahon to retireUnitedHealth COO Dirk McMahon to retire
healthcaredive.com - February 8 at 1:53 PM
UnitedHealth Groups president and COO Dirk McMahon to retireUnitedHealth Group's president and COO Dirk McMahon to retire
msn.com - February 8 at 8:52 AM
UnitedHealth Group Chief Operating Officer Dirk McMahon to retireUnitedHealth Group Chief Operating Officer Dirk McMahon to retire
bizjournals.com - February 8 at 8:52 AM
UnitedHealths chief operating officer Dirk McMahon to retireUnitedHealth's chief operating officer Dirk McMahon to retire
investing.com - February 7 at 10:49 PM
State of New Jersey Common Pension Fund D Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)State of New Jersey Common Pension Fund D Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)
marketbeat.com - February 7 at 9:58 PM
UnitedHealth, McDonalds share gains contribute to Dows 112-point jumpUnitedHealth, McDonald's share gains contribute to Dow's 112-point jump
msn.com - February 7 at 12:48 PM
UnitedHealthcare of California Awarded National Committee for Quality Assurance Health Equity AccreditationUnitedHealthcare of California Awarded National Committee for Quality Assurance Health Equity Accreditation
finance.yahoo.com - February 7 at 12:48 PM
Want to Get Richer? Here Are the 3 Best Stocks to Buy Now and Hold ForeverWant to Get Richer? Here Are the 3 Best Stocks to Buy Now and Hold Forever
fool.com - February 7 at 7:47 AM
CVS Health Beats on Earnings. It Expects Elevated Medical Costs This Year.CVS Health Beats on Earnings. It Expects Elevated Medical Costs This Year.
finance.yahoo.com - February 7 at 7:47 AM
Shayne & Jacobs LLC Acquires Shares of 6,947 UnitedHealth Group Incorporated (NYSE:UNH)Shayne & Jacobs LLC Acquires Shares of 6,947 UnitedHealth Group Incorporated (NYSE:UNH)
marketbeat.com - February 6 at 2:53 PM
Centene (CNC) Q4 Earnings Beat on Membership Growth, View UpCentene (CNC) Q4 Earnings Beat on Membership Growth, View Up
finance.yahoo.com - February 6 at 2:36 PM
UnitedHealthcare Launches Program to Address Type 2 Diabetes in Owensboro CommunityUnitedHealthcare Launches Program to Address Type 2 Diabetes in Owensboro Community
finance.yahoo.com - February 6 at 9:35 AM
10 Best Cheap Car Insurance in California for 202410 Best Cheap Car Insurance in California for 2024
finance.yahoo.com - February 5 at 6:07 PM
Charles Schwab Investment Management Inc. Purchases 27,127 Shares of UnitedHealth Group Incorporated (NYSE:UNH)Charles Schwab Investment Management Inc. Purchases 27,127 Shares of UnitedHealth Group Incorporated (NYSE:UNH)
marketbeat.com - February 5 at 3:58 PM
Sowell Financial Services LLC Has $6.20 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)Sowell Financial Services LLC Has $6.20 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)
marketbeat.com - February 4 at 11:49 AM
UNH short interest declines, indicating growing optimism among investorsUNH short interest declines, indicating growing optimism among investors
knoxdaily.com - February 2 at 8:41 PM
UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Amalgamated BankUnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Amalgamated Bank
marketbeat.com - February 2 at 4:39 PM
Brazilian Health Care Provider Dasa to Evaluate SaleBrazilian Health Care Provider Dasa to Evaluate Sale
finance.yahoo.com - February 1 at 7:26 PM
New York Life Investment Management LLC Reduces Holdings in UnitedHealth Group Incorporated (NYSE:UNH)New York Life Investment Management LLC Reduces Holdings in UnitedHealth Group Incorporated (NYSE:UNH)
marketbeat.com - February 1 at 3:29 PM
3 Growth Stocks That Have Raised Their Dividends for the Past 14+ Years3 Growth Stocks That Have Raised Their Dividends for the Past 14+ Years
fool.com - February 1 at 2:25 PM
Brokers Suggest Investing in UnitedHealth (UNH): Read This Before Placing a BetBrokers Suggest Investing in UnitedHealth (UNH): Read This Before Placing a Bet
finance.yahoo.com - February 1 at 2:25 PM
Summit Financial LLC Has $9.92 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)Summit Financial LLC Has $9.92 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)
marketbeat.com - January 31 at 3:41 PM
As UnitedHealth Tries To Rebound, Option Trade Can Return 18% By Mid-MarchAs UnitedHealth Tries To Rebound, Option Trade Can Return 18% By Mid-March
finance.yahoo.com - January 31 at 10:17 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

CRISPR Therapeutics logo

CRISPR Therapeutics

NASDAQ:CRSP
CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.
Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
CVS Health logo

CVS Health

NYSE:CVS
CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Eli Lilly and Company logo

Eli Lilly and Company

NYSE:LLY
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; Foghorn Therapeutics Inc., and PRISM BioLab Co.,Ltd. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Merck & Co., Inc. logo

Merck & Co., Inc.

NYSE:MRK
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV, as well as a collaboration with Bionomics to identify novel a7 nAChR PAMs suitable for the treatment of cognitive disorder; and clinical trial collaboration and supply agreement with Ankyra Therapeutics to evaluate ANK-101 in combination with KEYTRUDA (pembrolizumab) in patients with advanced solid tumors, as well as a clinical trial collaboration and supply agreement with Phanes Therapeutics, Inc. to evaluate PT886 in combination with KEYTRUDA for the treatment of claudin 18.2 positive gastric or gastroesophageal junction adenocarcinomas, as well as a development and commercialization agreement with Daiichi Sankyo Company, Limited to jointly develop and commercialize Daiichi Sankyo's DXd antibody drug conjugate (ADC) candidates and a collaboration with HiberCell, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Novartis logo

Novartis

NYSE:NVS
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. It offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc., as well as strategic partnership with CSPC Pharmaceutical Group Limited to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China, and a collaboration with Carrick Therapeutics Limited. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Teladoc Health logo

Teladoc Health

NYSE:TDOC
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its that licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
UnitedHealth Group logo

UnitedHealth Group

NYSE:UNH
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The OptumHealth segment provides care delivery, care management, wellness and consumer engagement, and health financial services for consumers, care delivery systems, providers, employers, payers, and public-sector entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.

My Account -